# Kiniksa Pharmaceuticals International, plc (KNSA) - Q1 2026 earnings

Reported April 28, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | $214.3M | $206.1M |
| EPS | $0.27 | $0.18 |

Earnings filing reader: [8-K 0001730430-26-000017](https://www.opencapital.sh/filings/0001730430-26-000017)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001730430-26-000017.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1730430/000173043026000017/0001730430-26-000017-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/1730430/000110465926050359/0001104659-26-050359-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/knsa/earnings/q1-2026